Sélection de la langue

Search

Sommaire du brevet 2427963 

Énoncé de désistement de responsabilité concernant l'information provenant de tiers

Une partie des informations de ce site Web a été fournie par des sources externes. Le gouvernement du Canada n'assume aucune responsabilité concernant la précision, l'actualité ou la fiabilité des informations fournies par les sources externes. Les utilisateurs qui désirent employer cette information devraient consulter directement la source des informations. Le contenu fourni par les sources externes n'est pas assujetti aux exigences sur les langues officielles, la protection des renseignements personnels et l'accessibilité.

Disponibilité de l'Abrégé et des Revendications

L'apparition de différences dans le texte et l'image des Revendications et de l'Abrégé dépend du moment auquel le document est publié. Les textes des Revendications et de l'Abrégé sont affichés :

  • lorsque la demande peut être examinée par le public;
  • lorsque le brevet est émis (délivrance).
(12) Brevet: (11) CA 2427963
(54) Titre français: DISPOSITIF D'ADMINISTRATION DE MEDICAMENTS
(54) Titre anglais: DRUG DELIVERY DEVICE
Statut: Périmé et au-delà du délai pour l’annulation
Données bibliographiques
Abrégés

Abrégé français

L'invention porte sur un dispositif d'administration de médicaments comprenant un tube d'administration et un piston allongé. Le tube d'administration possède une paroi tubulaire créant un passage et il est pourvu d'une extrémité où le médicament est admis dans le tube et d'une extrémité où le médicament est administré au patient. L'extrémité d'administration du médicament possède deux éléments radiaux et est pourvu d'un grillage souple composé de deux ensembles de bandes souples. Les première et deuxième bandes souples se prolongent respectivement à partir des premier et deuxième éléments radiaux de l'extrémité du tube où l'administration du médicament se fait. Le piston allongé possède une extrémité servant à pousser le médicament et une extrémité destinée à être manipulée par l'utilisateur, il est conçu pour glisser dans le passage et il possède une longueur suffisante pour permettre à son extrémité destinée à pousser le médicament de pousser le médicament dans le passage pour l'en faire sortir et le faire passer dans les deux jeux de bandes souples en vue de son administration dans une cavité corporelle.


Abrégé anglais

A drug delivery device includes an insert tube and an elongate plunger. The insert tube has a tubular wall that confines a passage and that has drug entrance and release ends. The drug release end has first and second radial parts, and is provided with a flexible grating that includes sets of first and second flexible strips. The first and second flexible strips extend from the first and second radial parts of the drug release end, respectively. The elongate plunger has a drug pushing end and an operating end, is slidably movable in the passage, and has a length sufficient to enable the drug pushing end to push a drug in the passage to move out of the passage and spread apart the first and second flexible strips for delivering the drug into a body cavity.

Revendications

Note : Les revendications sont présentées dans la langue officielle dans laquelle elles ont été soumises.


9
I CLAIM:
1. A drug delivery device, comprising:
an insert tube having a tubular wall that confines a
passage extending in an axial direction for receiving a
drug in solid form, said tubular wall having a drug
entrance end adapted for admitting a drug into said
passage, and a drug release end opposite to said drug
entrance end in the axial direction and adapted to be
inserted into a body cavity, said drug release end having
opposite first and second radial parts, said insert tube
being provided with a flexible grating at said drug
release end to hinder unforced removal of the drug from
said passage via said drug release end, said flexible
grating including a set of first flexible strips that
extend from said first radial part toward said second
radial part, and a set of second flexible strips that
extend from said second radial part toward said first
radial part, said first and second flexible strips being
in one of the form of: i) flexible thin rods and
ii) flexible wires, and having ends overlapping each
other; and
an elongate plunger having a drug pushing end and an
operating end opposite to said drug pushing end in the
axial direction, said plunger being slidably extended into
said passage via said drug entrance end of said tubular
wall such that said drug pushing end is disposed proximate
to said drug release end of said tubular wall, and such
that said operating end is disposed outwardly of said
passage and is adjacent to said drug entrance end of said
tubular wall, said plunger being movable in said passage
and having a length sufficient to enable said drug pushing

end to push the drug to move out of said passage at said
drug release end and spread apart said first and second
flexible strips of said flexible grating for delivering
the drug into the body cavity;
wherein said drug entrance end of said tubular wall
is formed with a first radial outward flange; and
wherein said operating end of said plunger is formed
with a second radial outward flange that abuts against
said first radial outward flange to prevent said operating
end of said plunger from extending into said passage.
2. A drug delivery device, comprising:
an insert tube having a tubular wall that confines a
passage extending in an axial direction for receiving a
drug in solid form, said tubular wall having a drug
entrance end adapted for admitting a drug into said
passage, and a drug release end opposite to said drug
entrance end in the axial direction and adapted to be
inserted into a body cavity, said drug release end having
opposite first and second radial parts, said insert tube
being provided with a flexible grating at said drug
release end to hinder unforced removal of the drug from
said passage via said drug release end, said flexible
grating including a set of first flexible strips that
extend from said first radial part toward said second
radial part, and a set of second flexible strips that
extend from said second radial part toward said first
radial part, said first and second flexible strips being
in one of the form of: i) flexible thin rods and
ii) flexible wires, and having ends overlapping each
other; and

11
an elongate plunger having a drug pushing end and an
operating end opposite to said drug pushing end in the
axial direction, said plunger being slidably extended into
said passage via said drug entrance end of said tubular
wall such that said drug pushing end is disposed proximate
to said drug release end of said tubular wall, and such
that said operating end is disposed outwardly of said
passage and is adjacent to said drug entrance end of said
tubular wall, said plunger being movable in said passage
and having a length sufficient to enable said drug pushing
end to push the drug to move out of said passage at said
drug release end and spread apart said first and second
flexible strips of said flexible grating for delivering
the drug into the body cavity;
wherein said plunger further has an intermediate
plunger part between said drug pushing end and said
operating end, said intermediate plunger part including a
plurality of axially extending and angularly spaced apart
radial wing plates that are in sliding contact with said
tubular wall.
3. The drug delivery device as claimed in claim 2,
wherein said intermediate plunger part is formed with a
radial friction rib adjacent to said operating end to
increase friction between said plunger and said insert
tube when said plunger is disposed at a preparation
position relative to said drug release end of said tubular
wall in preparation for delivering the drug into the body
cavity.
4. The drug delivery device as claimed in claim 2,
wherein said drug pushing end of said plunger is formed

12
with a plurality of vent holes that extend in the axial
direction.
5. A drug delivery device, comprising:
an insert tube having a tubular wall that confines a
passage extending in an axial direction for receiving a
drug in solid form, said tubular wall having a drug
entrance end adapted for admitting a drug into said
passage, and a drug release end opposite to said drug
entrance end in the axial direction and adapted to be
inserted into a body cavity, said drug release end having
opposite first and second radial parts, said insert tube
being provided with a flexible grating at said drug
release end to hinder unforced removal of the drug from
said passage via said drug release end, said flexible
grating including a set of first flexible strips that
extend from said first radial part toward said second
radial part, and a set of second flexible strips that
extend from said second radial part toward said first
radial part, said first and second flexible strips being
in one of the form of: i) flexible thin rods and
ii) flexible wires, and having ends overlapping each
other; and
an elongate plunger having a drug pushing end and an
operating end opposite to said drug pushing end in the
axial direction, said plunger being slidably extended into
said passage via said drug entrance end of said tubular
wall such that said drug pushing end is disposed proximate
to said drug release end of said tubular wall, and such
that said operating end is disposed outwardly of said
passage and is adjacent to said drug entrance end of said
tubular wall, said plunger being movable in said passage

13
and having a length sufficient to enable said drug pushing
end to push the drug to move out of said passage at said
drug release end and spread apart said first and second
flexible strips of said flexible grating for delivering
the drug into the body cavity;
wherein said drug pushing end of said plunger has a
convex pushing surface, and said first and second flexible
strips are curved strips that complement said pushing
surface of said drug pushing end.
6. ~The drug delivery device as claimed in claim 5,
wherein said tubular wall of said insert tube is shaped as
a circular cylinder.
7. ~The drug deliver device as claimed in claim 5,
wherein said tubular wall of said insert tube is shaped as
an oval cylinder.
8. ~The drug delivery device as claimed in claim 1,
wherein said tubular wall of said insert tube is shaped as
a circular cylinder.
9. ~The drug deliver device as claimed in claim 1,
wherein said tubular wall of said insert tube is shaped as
an oval cylinder.
10. ~The drug delivery device as claimed in claim 2,
wherein said tubular wall of said insert tube is shaped as
a circular cylinder.

14
11. ~The drug delivery device as claimed in claim 2,
wherein said tubular wall of said insert tube is shaped as
an oval cylinder

Description

Note : Les descriptions sont présentées dans la langue officielle dans laquelle elles ont été soumises.


CA 02427963 2003-05-06
~
DRUG DELIVERY DEVICE
Field of the Invention
The invention relates to a drug delivery device, more
particularly to a drug delivery device that dispenses
with the need to insert a finger into a body cavity during
the delivery process.
BRIEF DESCRIPTION OF THE DRAWINGS
In drawings which illustrate embodiment of the
invention,
Figure 1 illustrates a conventional way of delivering
a drug into a body cavity;
Figure 2 is an exploded schematic view of the
preferred embodiment of a drug delivery device according
to the present invention;
Figure 3 is an assembled schematic view of the
preferred embodiment;
Figure 4 illustrates the preferred embodi_ment in a
state of delivering a drug into a body cavity;
Figure 5 illustrates how the drug is hindered by a
flexible grating at a drug release end of an insert tube
of the preferred embodiment;
Figure 6 is a schematic end vieut-of the insert tube
to illustrate the flexible grating;
Figure 7 illustrates how the drug is pushed out of
the insert tube by a plunger of the pref_erred embodiment;
and
Figure 8 illustrates how a radial. outward flange of

CA 02427963 2003-05-06
2
the plunger is prevented from extending into the insert
tube.
BACKGROUND OF THE INVENTION
Suppositories are usually used for treating vaginal
infections or diseases in the anus. Mainly, the
suppository is inserted into the vagina or anus.
Referring to Figure 1, a conventional way of delivering
a drug 10 into a body cavity is done by aiming one end
11 of the drug 10 at the opening of the vagina or anus,
after which a finger is used to push the drug 1.0 deep
into the vagina or anus. However, this conventional way
of delivering the drug 10 into the body cavity has the
following disadvantages:
1. It is necessary to wash the hands thoroughly or to
use sterilized hand gloves during the drug delivery
process.
2. The inner wall of the vagina or anus is easily
scratched and injured by the fingernail on the
inserted finger, thereby resulting in pain.
3. The drug delivery process may induce emotional
trauma.
4. Because the drug cannot be delivered to a proper depth
and position due to the limited finger length, the
effect of the drug is reduced, thereby prolonging
the course of treatment.
SUMMARY OF THE INVENTION
Therefore, the main object of the present invention

CA 02427963 2003-05-06
3
is to provide a drug delivery device that dispenses with
the need to insert a finger into a body cavity during
the delivery process and that is simple to use.
Accordingly, a drug delivery device of this invention
comprises an insert tube and an elongate plunger. The
insert tube has a tubular wall that confines a passage
extending in an axial direction for receiving a drug
in solid form. The tubular wall has a drug entrance end
adapted for admitting the drug into the passage, and
a drug release end opposite to the drug entrance end
in the axial direction and adapted to be inserted into
a body cavity. The drug release end has opposite first
and second radial parts. The insert tube is provided
with a flexible grating at the drug release end so as
to hinder unforced removal of the drug from the passage
via the drug release end. The flexible grating includes
a set of first flexible strips that extend from the first
radial part toward the second radial part, and a set
of second flexible strips that extend from the second
radial part toward the first radial part. The elongate
plunger has a drug pushing end and an operating end
opposite to the drug pushing end in the axial direction.
The plunger is slidably extended into the passage via
the drug entrance end of the tubular wall such that the
drug pushing end is disposed proximate to the drug
release end of the tubular wall, and such that the
operating end is disposed outwardly of the passage and

CA 02427963 2003-05-06
4
is adjacent to the drug entrance end of the tubular wall.
The plunger is movable in the passage, and has a length
sufficient to enable the drug pushing end to push the
drug to move out of the passage at the drug release end
and spread apart the first and second flexible strips
of the flexible grating for delivering the drug into
the body cavity.
DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENT
Referring to Figures 2 to 8, the preferred embodiment
of a drug delivery device according to the present
invention is shown to comprise an insert tube 20 and
an elongate plunger 30. The insert tube 20 has a tubular
wall 22 that confines a passage 21 extending in an axial
direction (X) for receiving a drug 40 in solid form.
The tubular wall 22 can be shaped as a circular or oval
cylinder, and has a drug entrance end 221 and a drug
release end 222. The drug entrance end 221 is adapted
for admitting the drug 40 into the passage 21, and is
formed with a first radial outward flange 223. The drug
release end 222 is opposite to the drug entrance end
221 at a distance (L) in the axial direction (X), and
is adapted to be inserted into a body cavity. The drug
release end 222 has opposite first and second radial
parts 24, 25, and is provided with a flexible grating
26 so as to hinder unforced removal of the drug 40 from
the passage 21 via the drug release end 222, as best
shown in Figure 3. The flexible grating 26 is made of

CA 02427963 2003-05-06
a flexible material, and includes a set of first flexible
curved strips 241 and a set of second flexible curved
strips 251 (see Figures 2 and 3) . The first flexible
curved strips 241 extend from the first radial part 24
5 toward the second radial part 25. The second flexible
curved strips 251 extend from the second radial part
25 toward the first radial part 24.
The elongate plunger 30 has a drug pushing end 31
and an operating end 32 opposite to the drug pushing
end 31 in the axial direction (X) , and an intermediate
plunger part 33 between the drug pushing end 31 and the
operating end 32. The drug pushing end 31 is formed with
a plurality of vent holes 311. that extend in the axial
direction (X), and has a convex pushing surface. The
curved strips 241, 251 complement the pushing surface
of the drug pushing end 3l . The drug pushing end 31 further
has a diameter smaller than that of the passage 21 in
the insert tube 20. The operating end 32 is formed with
a second radial outward flange 321 that abuts against
the first radial outward flange 223 to prevent the
operating end 32 of the plunger 30 from extending into
the passage 21, as best shown in Figure 8. The
intermediate plunger part 33 includes four axially
extending and angularly spaced apart radial wing plates
332 that are in sliding contact with the tubular wall
22. Each of two opposite wing plates 332 is formed with
a radial friction rib 331 adjacent to the operating end

CA 02427963 2006-12-14
6
32 to increase friction between the plunger 30 and the
insert tube 20 when the plunger 30 is disposed at a
preparation position (P1) relative to the drug release end
222 of the tubular wall 22 in preparation for delivering
the drug 40 into the body cavity (see Figure 3) . The drug
40 is confined in the passage 21 at a space bounded by the
preparation position (Pl) and a release position (P2) of
the plunger 30.
The plunger 30 is slidably extended into the passage
21 via the drug entrance end 221 of the tubular wall 22
such that the drug pushing end 31 is disposed proximate to
the drug release end 222 of the tubular wall 22, and such
that the operating end 32 is disposed outwardly of the
passage 21 and is adjacent to the drug entrance end 221 of
the tubular wall 22. The plunger 30 is movable in the
passage 21 in the axial direction (X), and has a length
sufficient to enable the drug pushing end 31 to push the
drug 40 to move out of the passage 21 at the drug release
end 222 and spread apart the first and second flexible
strips 241, 251 of the flexible grating 26 for delivering
the drug 40 into the body cavity.
During use, after the drug 40 is disposed in the
passage 21 via the drug entrance end 221 of the insert
tube 20, the plunger 30 is inserted into the insert tube
20 such that the wing plates 332 are in sliding contact
with the tubular wall 22. The drug 40 is pushed by the
plunger 30 to the space between the preparation position

CA 02427963 2003-05-06
7
(Pi) and the release position (P2), and is confined
therebetween. At this time, the friction ribs 331 of
the wing plates 332 abut against the drug entrance end
221 of the tubular wall 22.
Referring back to Figure 4, the insert tube 20 is
then inserted into a proper depth of the vagina or anus.
The friction ribs 331 come into contact with the tubular
wall 22 as the operating end 32 of the plunger 30 is
pushed. The plunger 30 is pushed continuously until the
second radial outward flange 321 abuts against the first
radial outward flange 223, and the drug pushing end 31
of the plunger 30 reaches the drug release end 222 of
the insert tube 20, thereby pushing the drug 40 to move
out of the flexible grating 26 at the drug release end
222 and into the body cavity. Thus, the drug is
conveniently delivered into a proper depth and position
of the body cavity.
It should be noted that, when the drug delivery device
of the present invention is in use, the hands need not
come into contact with the drug 40 during the actual
delivery process so that sanitation can be maintained.
Furthermore, the drug delivery device of the present
inventionis simple and easy to operate. Moreover,'inj ury
to the body cavity can be minimized due to the cylindrical
shape of the insert tube 20 and the flexibility of the
flexible grating 26, thereby enhancing comfort during
use.

CA 02427963 2003-05-06
8
While the present invention has been described in
connection with what is considered the most practical
and preferred embodiment, it is understood that this
invention is not limited to the disclosed embodiment
but is intended to cover various arrangements included
within the spirit and scope of the br_oadest
interpretationso asto encompass all such modifications
and equivalent arrangements.

Dessin représentatif
Une figure unique qui représente un dessin illustrant l'invention.
États administratifs

2024-08-01 : Dans le cadre de la transition vers les Brevets de nouvelle génération (BNG), la base de données sur les brevets canadiens (BDBC) contient désormais un Historique d'événement plus détaillé, qui reproduit le Journal des événements de notre nouvelle solution interne.

Veuillez noter que les événements débutant par « Inactive : » se réfèrent à des événements qui ne sont plus utilisés dans notre nouvelle solution interne.

Pour une meilleure compréhension de l'état de la demande ou brevet qui figure sur cette page, la rubrique Mise en garde , et les descriptions de Brevet , Historique d'événement , Taxes périodiques et Historique des paiements devraient être consultées.

Historique d'événement

Description Date
Le délai pour l'annulation est expiré 2022-03-01
Lettre envoyée 2021-05-06
Lettre envoyée 2021-03-01
Lettre envoyée 2020-08-31
Inactive : COVID 19 - Délai prolongé 2020-08-19
Inactive : COVID 19 - Délai prolongé 2020-08-06
Inactive : COVID 19 - Délai prolongé 2020-07-16
Inactive : COVID 19 - Délai prolongé 2020-07-02
Inactive : COVID 19 - Délai prolongé 2020-06-10
Inactive : COVID 19 - Délai prolongé 2020-05-28
Inactive : COVID 19 - Délai prolongé 2020-05-14
Inactive : COVID 19 - Délai prolongé 2020-04-28
Représentant commun nommé 2019-10-30
Représentant commun nommé 2019-10-30
Demande visant la révocation de la nomination d'un agent 2018-09-14
Demande visant la nomination d'un agent 2018-09-14
Inactive : Regroupement d'agents 2018-09-01
Inactive : Regroupement d'agents 2018-08-30
Inactive : TME en retard traitée 2010-10-29
Lettre envoyée 2010-05-06
Accordé par délivrance 2008-07-22
Inactive : Page couverture publiée 2008-07-21
Préoctroi 2008-04-10
Inactive : Taxe finale reçue 2008-04-10
Lettre envoyée 2008-02-25
Un avis d'acceptation est envoyé 2008-02-25
Un avis d'acceptation est envoyé 2008-02-25
Inactive : CIB enlevée 2008-02-11
Inactive : Approuvée aux fins d'acceptation (AFA) 2007-12-11
Requête visant une déclaration du statut de petite entité reçue 2007-10-04
Déclaration du statut de petite entité jugée conforme 2007-10-04
Modification reçue - modification volontaire 2007-08-27
Inactive : Dem. de l'examinateur par.30(2) Règles 2007-02-28
Modification reçue - modification volontaire 2006-12-14
Inactive : Dem. de l'examinateur par.30(2) Règles 2006-06-29
Inactive : CIB de MCD 2006-03-12
Demande publiée (accessible au public) 2004-11-06
Inactive : Page couverture publiée 2004-11-05
Inactive : CIB attribuée 2003-06-23
Inactive : CIB en 1re position 2003-06-23
Inactive : Certificat de dépôt - RE (Anglais) 2003-06-06
Exigences de dépôt - jugé conforme 2003-06-06
Lettre envoyée 2003-06-06
Demande reçue - nationale ordinaire 2003-06-06
Exigences pour une requête d'examen - jugée conforme 2003-05-06
Toutes les exigences pour l'examen - jugée conforme 2003-05-06

Historique d'abandonnement

Il n'y a pas d'historique d'abandonnement

Taxes périodiques

Le dernier paiement a été reçu le 2008-04-10

Avis : Si le paiement en totalité n'a pas été reçu au plus tard à la date indiquée, une taxe supplémentaire peut être imposée, soit une des taxes suivantes :

  • taxe de rétablissement ;
  • taxe pour paiement en souffrance ; ou
  • taxe additionnelle pour le renversement d'une péremption réputée.

Veuillez vous référer à la page web des taxes sur les brevets de l'OPIC pour voir tous les montants actuels des taxes.

Historique des taxes

Type de taxes Anniversaire Échéance Date payée
Requête d'examen - petite 2003-05-06
Taxe pour le dépôt - petite 2003-05-06
TM (demande, 2e anniv.) - petite 02 2005-05-06 2005-04-07
TM (demande, 3e anniv.) - petite 03 2006-05-08 2006-04-18
TM (demande, 4e anniv.) - petite 04 2007-05-07 2007-04-30
TM (demande, 5e anniv.) - petite 05 2008-05-06 2008-04-10
Taxe finale - petite 2008-04-10
TM (brevet, 6e anniv.) - petite 2009-05-06 2009-04-24
Annulation de la péremption réputée 2010-05-06 2010-10-29
TM (brevet, 7e anniv.) - petite 2010-05-06 2010-10-29
TM (brevet, 8e anniv.) - petite 2011-05-06 2011-05-03
TM (brevet, 9e anniv.) - petite 2012-05-07 2012-04-19
TM (brevet, 10e anniv.) - petite 2013-05-06 2013-04-29
TM (brevet, 11e anniv.) - petite 2014-05-06 2014-04-23
TM (brevet, 12e anniv.) - petite 2015-05-06 2015-04-13
TM (brevet, 13e anniv.) - petite 2016-05-06 2016-03-28
TM (brevet, 14e anniv.) - petite 2017-05-08 2017-04-24
TM (brevet, 15e anniv.) - petite 2018-05-07 2018-04-24
TM (brevet, 16e anniv.) - petite 2019-05-06 2019-05-01
Titulaires au dossier

Les titulaires actuels et antérieures au dossier sont affichés en ordre alphabétique.

Titulaires actuels au dossier
DEBORAH HUANG
Titulaires antérieures au dossier
S.O.
Les propriétaires antérieurs qui ne figurent pas dans la liste des « Propriétaires au dossier » apparaîtront dans d'autres documents au dossier.
Documents

Pour visionner les fichiers sélectionnés, entrer le code reCAPTCHA :



Pour visualiser une image, cliquer sur un lien dans la colonne description du document. Pour télécharger l'image (les images), cliquer l'une ou plusieurs cases à cocher dans la première colonne et ensuite cliquer sur le bouton "Télécharger sélection en format PDF (archive Zip)" ou le bouton "Télécharger sélection (en un fichier PDF fusionné)".

Liste des documents de brevet publiés et non publiés sur la BDBC .

Si vous avez des difficultés à accéder au contenu, veuillez communiquer avec le Centre de services à la clientèle au 1-866-997-1936, ou envoyer un courriel au Centre de service à la clientèle de l'OPIC.


Description du
Document 
Date
(aaaa-mm-jj) 
Nombre de pages   Taille de l'image (Ko) 
Description 2003-05-06 8 301
Abrégé 2003-05-06 1 25
Dessins 2003-05-06 8 92
Revendications 2003-05-06 3 108
Dessin représentatif 2003-09-22 1 9
Page couverture 2004-10-14 1 38
Dessin représentatif 2006-11-09 1 10
Abrégé 2006-12-14 1 21
Description 2006-12-14 8 293
Revendications 2006-12-14 5 170
Revendications 2007-08-27 6 199
Page couverture 2008-07-08 1 39
Accusé de réception de la requête d'examen 2003-06-06 1 173
Certificat de dépôt (anglais) 2003-06-06 1 158
Rappel de taxe de maintien due 2005-01-10 1 109
Avis du commissaire - Demande jugée acceptable 2008-02-25 1 164
Avis concernant la taxe de maintien 2010-06-17 1 170
Quittance d'un paiement en retard 2010-10-29 1 164
Quittance d'un paiement en retard 2010-10-29 1 164
Avis du commissaire - Non-paiement de la taxe pour le maintien en état des droits conférés par un brevet 2020-10-19 1 548
Courtoisie - Brevet réputé périmé 2021-03-29 1 540
Avis du commissaire - Non-paiement de la taxe pour le maintien en état des droits conférés par un brevet 2021-06-17 1 558
Taxes 2012-04-19 1 153
Taxes 2005-04-07 1 32
Taxes 2006-04-18 1 42
Taxes 2007-04-30 1 43
Correspondance 2007-10-04 2 72
Correspondance 2008-04-10 1 30
Taxes 2008-04-10 1 43
Taxes 2009-04-24 1 43
Taxes 2010-10-29 1 198
Taxes 2011-05-03 1 200